Profile data is unavailable for this security.
About the company
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
- Revenue in JPY (TTM)3.51tn
- Net income in JPY37.24bn
- Incorporated1923
- Employees12.80k
- LocationMedipal Holdings Corp3-1-1, KyobashiCHUO-KU 104-0031JapanJPN
- Phone+81 335175800
- Fax+81 335175028
- Websitehttps://www.medipal.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Toho Holdings Co Ltd | 1.45tn | 17.57bn | 305.73bn | 7.70k | 16.52 | 1.04 | 12.62 | 0.2108 | 242.08 | 242.08 | 20,008.50 | 3,831.19 | 1.81 | 14.05 | 4.05 | 188,375,100.00 | 2.20 | 1.83 | 6.09 | 4.35 | 7.94 | 8.60 | 1.21 | 0.9786 | 1.05 | -- | 0.1298 | 18.14 | 9.67 | 2.73 | 1.88 | -1.07 | -22.49 | 1.30 |
| China Meheco Group Co Ltd | 858.76bn | 11.95bn | 352.95bn | 8.31k | 29.54 | 1.49 | -- | 0.411 | 0.3764 | 0.3764 | 27.05 | 7.48 | 1.13 | 5.58 | 2.76 | 4,868,542.00 | 2.05 | 4.09 | 4.44 | 9.37 | 11.07 | 15.92 | 1.81 | 3.38 | 1.16 | 21.23 | 0.3262 | 38.19 | 3.75 | 4.37 | 13.70 | -10.94 | 12.63 | -4.53 |
| China Medical System Holdings Ltd | 170.27bn | 51.02bn | 355.86bn | 5.70k | 6.98 | 1.08 | 6.41 | 2.09 | 1.06 | 1.06 | 3.53 | 6.84 | 0.4517 | 3.42 | 6.19 | 1,518,738.00 | 13.44 | 18.44 | 15.70 | 21.14 | 76.24 | 75.47 | 29.76 | 34.26 | 3.98 | -- | 0.0772 | 40.14 | -12.43 | 8.08 | -26.33 | 5.35 | 38.69 | 5.19 |
| Suzuken Co Ltd | 2.37tn | 27.68bn | 374.79bn | 13.43k | 14.31 | 0.9207 | 10.31 | 0.1581 | 336.97 | 336.97 | 28,802.96 | 5,236.47 | 1.82 | 12.94 | 4.05 | 176,574,900.00 | 2.12 | 1.77 | 6.33 | 4.64 | 7.75 | 8.05 | 1.17 | 0.9199 | 0.9883 | -- | 0.00 | 31.44 | 3.38 | 1.74 | 41.35 | 1.57 | 17.43 | 5.92 |
| Alfresa Holdings Corporation | 2.83tn | 31.84bn | 484.79bn | 11.77k | 14.65 | 0.9625 | 10.70 | 0.1714 | 163.14 | 163.14 | 14,454.60 | 2,483.23 | 1.92 | 15.08 | 4.12 | 240,225,700.00 | 2.17 | 2.47 | 6.17 | 6.52 | 7.24 | 7.34 | 1.13 | 1.24 | 1.03 | -- | 0.0607 | 33.25 | 4.27 | 0.7057 | -19.87 | -6.24 | 15.54 | 7.89 |
| Medipal Holdings Corp | 3.51tn | 37.24bn | 549.47bn | 12.80k | 14.12 | 0.8992 | 8.44 | 0.1567 | 175.85 | 175.85 | 16,560.73 | 2,761.44 | 1.91 | 16.34 | 4.40 | 274,130,900.00 | 2.60 | 2.62 | 7.75 | 7.32 | 6.85 | 6.90 | 1.37 | 1.34 | 1.01 | -- | 0.00 | 27.22 | 2.10 | 1.32 | 31.89 | 2.21 | -15.04 | 6.23 |
| China National Medicines Corp Ltd | 1.07tn | 46.49bn | 556.33bn | 3.14k | 11.97 | 1.62 | -- | 0.5182 | 2.90 | 2.90 | 67.05 | 21.51 | 1.61 | 11.21 | 6.58 | 16,122,340.00 | 7.57 | 7.32 | 14.41 | 15.03 | 7.63 | 8.15 | 4.70 | 4.31 | 1.77 | -- | 0.1271 | 30.04 | 9.23 | 5.11 | 9.26 | 8.85 | 1.84 | 16.38 |
| China Resources Pharmaceutical Group Ltd | 5.20tn | 81.90bn | 626.39bn | 72.99k | 7.65 | 0.6414 | 2.69 | 0.1205 | 0.6629 | 0.6629 | 42.09 | 7.90 | 1.06 | 7.06 | 3.84 | 3,622,635.00 | 3.36 | 3.02 | 12.72 | 11.35 | 15.67 | 15.72 | 3.18 | 2.87 | 1.09 | 8.70 | 0.412 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
| EBOS Group Ltd | 1.28tn | 25.92bn | 630.85bn | 5.20k | 24.13 | 2.63 | 15.48 | 0.4942 | 1.48 | 1.48 | 72.53 | 13.57 | 1.90 | 8.79 | 8.35 | 2,683,006.00 | 3.94 | 4.32 | 6.35 | 7.62 | 12.49 | 11.47 | 2.08 | 1.98 | 0.7358 | 6.79 | 0.4402 | 76.77 | 14.00 | 11.86 | 25.06 | 13.04 | 11.11 | 10.05 |
| Jointown Pharmaceutical Group Co Ltd | 3.15tn | 46.01bn | 680.94bn | 30.10k | 15.01 | 1.31 | -- | 0.2161 | 0.5469 | 0.5469 | 37.57 | 6.28 | 1.53 | 8.05 | 3.96 | 4,934,201.00 | 2.31 | 3.01 | 7.85 | 9.72 | 7.68 | 8.24 | 1.50 | 1.98 | 0.9782 | 3.50 | 0.5673 | 34.73 | 6.92 | 11.50 | 4.88 | 14.16 | -10.39 | 39.14 |
Data as of May 02 2024. Currency figures normalised to Medipal Holdings Corp's reporting currency: Japanese Yen JPY
26.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 31 Mar 2023 | 26.52m | 11.98% |
| Nomura Asset Management Co., Ltd.as of 30 Sep 2022 | 7.37m | 3.33% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 6.55m | 2.96% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 3.30m | 1.49% |
| Schroder Investment Management Ltd.as of 31 Dec 2023 | 3.30m | 1.49% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 3.21m | 1.45% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 2.48m | 1.12% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 2.08m | 0.94% |
| Geode Capital Management LLCas of 04 Apr 2024 | 1.92m | 0.87% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 1.57m | 0.71% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
